IDEAYA Biosciences, Inc.
IDYA
$40.17
$0.220.55%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 35.02% | -39.68% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 35.02% | -39.68% | |||
| Cost of Revenue | -90.12% | 10.54% | |||
| Gross Profit | 99.33% | -17.75% | |||
| SG&A Expenses | 15.90% | 2.82% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 13.94% | 9.16% | |||
| Operating Income | -12.66% | -14.78% | |||
| Income Before Tax | -14.12% | -18.33% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -14.12% | -18.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -14.12% | -18.33% | |||
| EBIT | -12.66% | -14.78% | |||
| EBITDA | -12.75% | -14.93% | |||
| EPS Basic | -9.96% | -18.17% | |||
| Normalized Basic EPS | -9.95% | -5.53% | |||
| EPS Diluted | -9.96% | -17.68% | |||
| Normalized Diluted EPS | -9.95% | -5.53% | |||
| Average Basic Shares Outstanding | 3.79% | 0.13% | |||
| Average Diluted Shares Outstanding | 3.79% | 0.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||